Professional Documents
Culture Documents
Alcoholic Liver Disease
Alcoholic Liver Disease
Alcoholic Liver Disease
DR ALEX MOGERE.
CONSULTANT PHYSICIAN
Spectrum of alcoholic liver disease
1) Fatty liver/steatosis >90%
3) Cirrhosis 10-20%
↓
4) Hepatocellular carcinoma
Risk factors in development of Alcoholic
liver disease.
Quantity & duration of alcohol use
Genetics:
Sex: Females more susceptible >males in
progression of liver disease
Non gender linked genetic factors
Metabolic traits
Diet & Obesity
Risk factors :Quantity & Duration
Risk of development of ALD starts at 30gms/day of
ethanol
But for most individuals the dose that confers
significant risk is >80gms/day
Studies show that males consuming >160gms/day
for>8yrs developed cirrhosis
Wine drinkers have lower risk >beer & spirit
drinkers
Daily drinking worse effect >intermittent as the
latter gives liver opportunity to recover
Alcohol abuse vs dependence
• Alcohol abusers- drink despite recurrent
interpersonal, social or legal problems
• Dependence: presence of 3 or > of the following:
• Tolerance
• Withdrawal symptoms
• Loss of control over drinking
• Strong desire to drink
• Drinking despite harm
Detection of alcohol abuse
• CAGE(cut down, annoyed by criticism,Guilty
about drinking,Eye opener in the morning)
• AUDIT(alcohol use disorders identification
tests)-a 10 item questionnare
Alcohol metabolism
Physical exam:
Hepatomegally +/-tender
Vascular spider +/-
Features of CLD +/-
Clinical features/Syndrome
Fatty liver:
Usually asymptomatic
+/-Tender smooth ,firm palpable liver
Liver biopsy:
Rarely required to exclude other causes;
Differentiates steatosis from steatohepatitis & alcoholic
hepatitis from cirrhosis
Treatment of ALD
General/universal issues:
1) Corticosteroids:
suppresses hepatic inflammatory response & most effective therapy
However C/I in active sepsis & bleeding: If present treat then start
steroid
Failure of drop of bilirubin level by day 7 is indicative of steroid non
responsive: these patients have poor prognosis.
Increase albumin prdn
Antifibrotic
Improves caloric intake by increasing appetite
32 mg p.o x 4/52 then taper
Prednisolone preferred over prednisone
Ct .prednisolone
Ideal patient has:
• MDF > 32 with spont encephalopathy.
C/I:
• Active G/I bleeds,
• HRS
• Sepsis
• AVH
Pentoxyfilline
• Attenuates TNF a release and action
• Decreases blood viscousity
• Lower portal htn
• Antifibrogenic
• Improves organ microcirculation
• Tissue oxygenation
• 400mg tid x 4 weeks
Treatment of ALD: Acute alcoholic hepatitis
2) Pentoxifyillin:
Give in those in whom steroid is C/I
Improves survival in severe disease by 40%
Treat complications